Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 454 shares. Based on an average trading volume of 422 shares, the days-to-cover ratio is currently 1.1 days.
Hikma Pharmaceuticals Stock Performance
Shares of HKMPY stock remained flat at $42.03 during trading hours on Wednesday. 349 shares of the stock traded hands, compared to its average volume of 1,255. The firm has a 50 day moving average price of $43.31 and a 200 day moving average price of $40.64. Hikma Pharmaceuticals has a 12-month low of $31.80 and a 12-month high of $49.31.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC is a global pharmaceutical company headquartered in London, United Kingdom. Founded in 1978 by Samih Darwazah in Jordan, the company develops, manufactures and markets a broad range of prescription medicines for healthcare providers and patients.
Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its portfolio includes hospital injectable products, specialty and generic medicines, and branded pharmaceutical products in areas such as respiratory care, cardiovascular treatment, pain management, anti-infectives and central nervous system therapies.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
- How a Hurricane Could Help Some Refineries—and Hurt Others
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
